𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Primum non nocere: Safety in clinical trials for IPF

✍ Scribed by Joyce S. Lee; Harold R. Collard

Book ID
108965546
Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
107 KB
Volume
16
Category
Article
ISSN
1323-7799

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Benefit–risk analysis for the clinician:
Benefit–risk analysis for the clinician: β€˜primum non nocere’ revisitedβ€”the case for antipsychotics in the treatment of behavioural disturbances in dementia
✍ P. Naarding; M. van Grevenstein; A. T. F. Beekman πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 134 KB

## Abstract The results of clinical trials are often presented in a way that only highlights either the benefits or the risks of the treatment under study. Especially in older age, clinical psychiatric problems are often of complex nature, which requires integrating multiple sources of data to reac

ADJUSTING FOR NON-COMPLIANCE AND CONTAMI
ADJUSTING FOR NON-COMPLIANCE AND CONTAMINATION IN RANDOMIZED CLINICAL TRIALS
✍ JACK CUZICK; ROBERT EDWARDS; NEREO SEGNAN πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 290 KB πŸ‘ 2 views

A method of analysis is presented for estimating the magnitude of a treatment effect among compliers in a clinical trial which is asymptotically unbiased and respects the randomization. The approach is valid even when compliers have a different baseline risk than non-compliers. Adjustments for conta